Propranolol

"Propranolol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.

Descriptor ID	D011433
MeSH Number(s)	D02.033.100.624.698.711 D02.033.755.624.698.711 D02.092.063.624.698.711 D02.455.426.559.847.638.945 D04.615.638.945
Concept/Terms	Propranolol Propranolol Propanolol Inderal Inderal Avlocardyl Avlocardyl AY-20694 AY-20694 AY 20694 AY20694 Rexigen Rexigen Dexpropranolol Dexpropranolol Dociton Dociton Obsidan Obsidan Obzidan Propranolol Hydrochloride Propranolol Hydrochloride Hydrochloride, Propranolol Anaprilin Anaprilin Anapriline Betadren Betadren

Below are MeSH descriptors whose meaning is more general than "Propranolol".

Chemicals and Drugs [D]
Organic Chemicals [D02]
Alcohols [D02.033]
Amino Alcohols [D02.033.100]
Propanolamines [D02.033.100.624]
Phenoxypropanolamines [D02.033.100.624.698]
Propranolol [D02.033.100.624.698.711]
Propanols [D02.033.755]
Propanolamines [D02.033.755.624]
Phenoxypropanolamines [D02.033.755.624.698]
Propranolol [D02.033.755.624.698.711]
Amines [D02.092]
Amino Alcohols [D02.092.063]
Propanolamines [D02.092.063.624]
Phenoxypropanolamines [D02.092.063.624.698]
Propranolol [D02.092.063.624.698.711]
Hydrocarbons [D02.455]
Hydrocarbons, Cyclic [D02.455.426]
Hydrocarbons, Aromatic [D02.455.426.559]
Polycyclic Aromatic Hydrocarbons [D02.455.426.559.847]
Naphthalenes [D02.455.426.559.847.638]
Propranolol [D02.455.426.559.847.638.945]
Polycyclic Compounds [D04]
Polycyclic Aromatic Hydrocarbons [D04.615]
Naphthalenes [D04.615.638]
Propranolol [D04.615.638.945]

Below are MeSH descriptors whose meaning is more specific than "Propranolol".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Propranolol" by people in this website by year, and whether "Propranolol" was a major or minor topic of these publications.

Bar chart showing 23 publications over 16 distinct years, with a maximum of 4 publications in 1999

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1997	1	0	1
1998	0	1	1
1999	2	2	4
2000	0	1	1
2003	0	2	2
2004	0	1	1
2005	0	1	1
2006	0	1	1
2007	0	2	2
2010	0	2	2
2012	1	0	1
2014	1	1	2
2015	1	0	1
2018	0	1	1
2020	0	1	1
2024	1	0	1

Below are the most recent publications written about "Propranolol" by people in Profiles.

Biswas S, Toro M, Horgan R, McLaren RA, Berghella V, Al-Kouatly HB. Propranolol to decrease time to delivery: a meta-analysis of randomized controlled trials. Am J Obstet Gynecol MFM. 2024 Oct; 6(10):101459.

View in: PubMed
Kopruszinski CM, Navratilova E, Swiokla J, Dodick DW, Chessell IP, Porreca F. A novel, injury-free rodent model of vulnerability for assessment of acute and preventive therapies reveals temporal contributions of CGRP-receptor activation in migraine-like pain. Cephalalgia. 2021 03; 41(3):305-317.

View in: PubMed
Levin MD, Saitta SC, Gripp KW, Wenger TL, Ganesh J, Kalish JM, Epstein MR, Smith R, Czosek RJ, Ware SM, Goldenberg P, Myers A, Chatfield KC, Gillespie MJ, Zackai EH, Lin AE. Nonreentrant atrial tachycardia occurs independently of hypertrophic cardiomyopathy in RASopathy patients. Am J Med Genet A. 2018 08; 176(8):1711-1722.

View in: PubMed
Orrey DC, Halawa OI, Bortsov AV, Shupp JW, Jones SW, Haith LR, Hoskins JM, Jordan MH, Bangdiwala SI, Roane BR, Platts-Mills TF, Holmes JH, Hwang J, Cairns BA, McLean SA. Results of a pilot multicenter genotype-based randomized placebo-controlled trial of propranolol to reduce pain after major thermal burn injury. Clin J Pain. 2015 Jan; 31(1):21-9.

View in: PubMed
Bollmann A, Hilbert S, John S, Kosiuk J, Hindricks G. Insights from preclinical ultra high-density electroanatomical sinus node mapping. Europace. 2015 Mar; 17(3):489-94.

View in: PubMed
Penn RB. Far from "disappointing". Am J Respir Crit Care Med. 2014 Feb 01; 189(3):360.

View in: PubMed
Silberstein SD, Dodick DW, Lindblad AS, Holroyd K, Harrington M, Mathew NT, Hirtz D. Randomized, placebo-controlled trial of propranolol added to topiramate in chronic migraine. Neurology. 2012 Mar 27; 78(13):976-84.

View in: PubMed
Holinstat M, Boutaud O, Apopa PL, Vesci J, Bala M, Oates JA, Hamm HE. Protease-activated receptor signaling in platelets activates cytosolic phospholipase A2a differently for cyclooxygenase-1 and 12-lipoxygenase catalysis. Arterioscler Thromb Vasc Biol. 2011 Feb; 31(2):435-42.

View in: PubMed
O-Uchi J, Lopes CM. Combined blockade of ?- and a1-adrenoceptors in left ventricular remodeling induced by hypertension: beneficial or not? Hypertens Res. 2010 Oct; 33(10):984-5.

View in: PubMed
Medeiros FL, Medeiros PL, Valen?a MM, Dodick D. Simvastatin for migraine prevention. Headache. 2007 Jun; 47(6):855-6.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement